Delcath Systems, Inc. (NASDAQ:DCTH – Free Report) – Research analysts at HC Wainwright dropped their Q2 2026 EPS estimates for shares of Delcath Systems in a research report issued on Friday, May 8th. HC Wainwright analyst S. Ramakanth now expects that the company will earn ($0.16) per share for the quarter, down from their previous forecast of ($0.15). The consensus estimate for Delcath Systems’ current full-year earnings is ($0.86) per share. HC Wainwright also issued estimates for Delcath Systems’ Q3 2026 earnings at ($0.29) EPS, Q4 2026 earnings at ($0.43) EPS, FY2026 earnings at ($0.88) EPS, FY2027 earnings at ($1.23) EPS, FY2028 earnings at ($0.27) EPS, FY2029 earnings at $0.43 EPS and FY2030 earnings at $1.03 EPS.
Delcath Systems (NASDAQ:DCTH – Get Free Report) last issued its earnings results on Thursday, May 7th. The company reported ($0.03) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.10) by $0.07. Delcath Systems had a net margin of 0.62% and a return on equity of 0.51%. The company had revenue of $24.99 million for the quarter, compared to analysts’ expectations of $23.51 million.
View Our Latest Analysis on DCTH
Delcath Systems Stock Performance
NASDAQ:DCTH opened at $11.06 on Tuesday. Delcath Systems has a fifty-two week low of $8.12 and a fifty-two week high of $18.23. The stock has a market capitalization of $381.79 million, a P/E ratio of 1,106.00 and a beta of 0.54. The company’s 50-day simple moving average is $9.93 and its 200-day simple moving average is $9.81.
Hedge Funds Weigh In On Delcath Systems
Several hedge funds and other institutional investors have recently modified their holdings of the stock. Deutsche Bank AG raised its position in shares of Delcath Systems by 5.4% in the 4th quarter. Deutsche Bank AG now owns 24,162 shares of the company’s stock valued at $244,000 after purchasing an additional 1,248 shares during the last quarter. California State Teachers Retirement System purchased a new position in shares of Delcath Systems in the 2nd quarter valued at approximately $26,000. Intech Investment Management LLC raised its position in shares of Delcath Systems by 13.1% in the 4th quarter. Intech Investment Management LLC now owns 17,595 shares of the company’s stock valued at $178,000 after purchasing an additional 2,035 shares during the last quarter. AWM Investment Company Inc. raised its position in shares of Delcath Systems by 3.9% in the 4th quarter. AWM Investment Company Inc. now owns 60,000 shares of the company’s stock valued at $606,000 after purchasing an additional 2,279 shares during the last quarter. Finally, Russell Investments Group Ltd. purchased a new position in shares of Delcath Systems in the 3rd quarter valued at approximately $29,000. 61.12% of the stock is owned by hedge funds and other institutional investors.
About Delcath Systems
Delcath Systems, Inc is a specialty pharmaceutical and medical technology company focused on the development and commercialization of its proprietary Hepatic CHEMOSAT® Delivery System, designed to deliver high-dose chemotherapeutic agents directly to the liver while minimizing systemic exposure. The company’s core technology performs isolated hepatic perfusion, enabling oncologists to administer concentrated melphalan to patients with primary and metastatic liver tumors, including those arising from ocular melanoma.
Featured Stories
- Five stocks we like better than Delcath Systems
- TMC Forges a New EV Supply Chain at the Bottom of the Sea
- Sell in May and Go Away—Starting With These 3 Stocks
- Before the Moon Base Gets Built, These 4 Companies Win
- Industrial Buybacks: Top Homebuilding Supplier Leads Buyback Increases
Receive News & Ratings for Delcath Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Delcath Systems and related companies with MarketBeat.com's FREE daily email newsletter.
